Post-Approval Study Finds No Surprises With Argus II Retinal Implant

Source: Reuters

Post-approval follow-up of the Argus II Retinal Prosthesis System shows safety and visual function outcomes similar to those in previous trials, according to a company-funded study, as reported in Reuters.

With a CE mark granted in 2011, the device became the first retinal prosthesis to be approved for use in Europe.

For the new work, Dr. Jessy D. Dorn of Second Sight Medical Products, in Sylmar, California, and colleagues studied data from nine sites in Italy and Germany. The 47 patients included in the study, most of whom (79%) had retinitis pigmentosa, were followed for at least a year after implantation.

Read the full article.

Related Content